[Drugs and teratogen monitoring. Experience in the Rhone-Alpes-Auvergne regions].
作者信息
Robert E, Francannet C, Robert J M
出版信息
Therapie. 1985 Sep-Oct;40(5):293-6.
PMID:4095684
Abstract
摘要
相似文献
1
[Drugs and teratogen monitoring. Experience in the Rhone-Alpes-Auvergne regions].[药物与致畸剂监测。罗讷-阿尔卑斯大区-奥弗涅大区的经验]
Therapie. 1985 Sep-Oct;40(5):293-6.
2
[Registries of malformations in the Rhône-Alps/Auvergne region. Value and limits of monitoring teratogenesis. 11 years' experience (1976-1986)].[罗讷-阿尔卑斯大区/奥弗涅地区的畸形登记。监测致畸作用的价值与局限性。11年经验（1976 - 1986年）]
J Gynecol Obstet Biol Reprod (Paris). 1988;17(5):601-7.
3
[Monitoring of pregnancies exposed to drugs in France: the experience of the registries of congenital malformations].[法国孕期药物暴露监测：先天性畸形登记处的经验]
Therapie. 2014 Jan-Feb;69(1):47-51. doi: 10.2515/therapie/2014006. Epub 2014 Apr 4.
4
[Registry for congenital malformations].[先天性畸形登记处]
Duodecim. 1971;87(21):1409-11.
5
Epidemiology of malformations: inspiration and perspiration.
Teratology. 1974 Dec;10(3):217-20. doi: 10.1002/tera.1420100303.
6
Congenital defects and environmental factors during pregnancy: nationwide surveillance.
Prog Clin Biol Res. 1985;163B:287-9.
7
[Epidemiologic methods in teratology].
Duodecim. 1974;90(22):1554-64.
8
The Finnish register of congenital malformations.芬兰先天性畸形登记册。
Acta Univ Carol Med Monogr. 1973;56:23-30.
9
[Evaluation of teratogenic risk: the contribution of abnormalities registries].[致畸风险评估：异常登记处的贡献]
Rev Epidemiol Sante Publique. 1994;42(5):392-8.
10
[Monitoring of the pathogenesis of congenital abnormalities].
Orv Hetil. 1983 Aug 28;124(35):2121-5.
Zotero 插件